NEWS & EVENTS

The Latest from Evaluate

Find out the latest news from Evaluate, check out the views from our thought leaders and see where we’ll be exhibiting in the coming months.

Upcoming Events & Conferences

Find out where we’ll be and arrange to come and meet the team.

Bio Europe

Join Evaluate at BIO Europe and connect with delegates spanning the global life science ecosystem to propel dealmaking and innovation.

Come visit Booth #82 and find out how Evaluate provides insights and guidance for both big pharmaceutical companies and biotechs on how to navigate licensing deals and maximise the success of their partnerships.

We understand the challenges of navigating through numerous potential partners and opportunities, which is why our dedicated team of advisory experts is here to assist. With our dynamic prioritization models, deep dives into priority targets, and insights for asset acquisition or divestiture, we can simplify your decision-making process and help you make the most out of Bio Europe.

Meet with Evaluate at BIO Europe via PartneringONE.

Thought Leadership

From trials to triumph: Forecasting across the product lifecycle

Access our expert guide, ‘From trials to triumph: Forecasting across the product lifecycle’...

evaluate-featured-image-obesity-infographic

What’s next for obesity?

Solid proof now exists that pharmacological intervention can help shift excess body weight. Yet, many...

Forecasting for Rare Diseases

Navigating the complex landscape of rare diseases requires a specialized approach. With over 7,000 types...

Quarterly Round Up: One Step Forward, Q2 Steps Back

Going into 2024, hopes were moderately high for dealmaking and the wider financial landscape in pharma....

evaluate-featured-image-quarterly-round-up

Quarterly Round Up: One Step Forward, Q2 Steps Back

We began 2024 on solid footing, taking a tentative step forward with promising deal-making and financial...

Obesity: The Next Questions

Before the incretin drug class proved its potential, the notion that obesity could be treated with a...

evaluate-featured-image-blockbuster-infographic

Billion Dollar Blueprint: The Journey to Blockbuster Status

Do the pharmaceutical industry’s billion-dollar drugs have an X-factor? To better understand the blockbuster...

Billion Dollar Blueprint: The Journey to Blockbuster Status

Developing blockbuster drugs as anchors in their portfolios is a key commercial goal for pharmaceutical...

World Preview 2024 – Pharma’s Growth Boost - eBook

Last year’s Age of Uncertainty has given way to more predictable realities. Obesity drugs are set to...

World Preview 2024 – Pharma’s Growth Boost - Infographic

After an Age of Uncertainty, the pharmaceutical industry is now shifting into a period with more predictable...

Latest Press Releases

Norstella Introduces NorstellaLinQ, the Biopharma Industry’s First Fully Integrated Data Asset

NEW YORK – October 8, 2024 – Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first...

evaluate-featured-image-world-preview-press-release

Evaluate Releases 2030 Forecasts for Global Pharmaceutical Market

2024 World Preview Report shows a market set to hit $1.7tn in 2030, driven by a shift to “big drugs for...

Evaluate’s 2024 Orphan Drug Report Signals Slow Down in Growth

LONDON – 24 April 2024 – Evaluate, the leading provider of market insights for the pharmaceutical...

Inpart and Evaluate Announce Strategic Partnership to Optimise Biopharma Dealmaking

Lyon, France 4th March 2024: In a landmark collaboration, Inpart (previously Inova), a trailblazing software...

acquisition-J-D-Forecasting-fetured-image

Evaluate, a Norstella Company, Announces Acquisition of J+D Forecasting

London, UK and Boston, MA – 10th January 2024: Evaluate, a Norstella company, announced today the acquisition...

Evaluate-Launches-CDMO-Intelligence-Solution-featured-image

Evaluate Launches CDMO Intelligence Solution to Support Rapidly Expanding Pharmaceutical CDMO Market

London, UK and Boston, MA – 3rd October 2023: Evaluate, a Norstella company, has announced today the...

Evaluate-Expands-Competitive-Intelligence-Practice-featured-image

Evaluate Expands its Competitive Intelligence Practice

London, UK and Boston, MA – 19th Sept 2023: Evaluate Ltd, a Norstella company, announced today the expansion...

Evaluate-Forecasts-Global-Pharmaceutical-Worth-more-2028-featured-image

Evaluate Forecasts Global Pharmaceutical Market to Be Worth $1.6tn in 2028

London, UK and Boston, MA – 15th August 2023: Global pharmaceutical revenues are forecast to grow at...

Solactive-Evaluate-Global-Pharma-Index-featured-image

Solactive and Evaluate Launch Solactive Evaluate Global Pharma Index, Their First Co-Branded Index

FRANKFURT AM MAIN – With rapid advancements in medical research, technology, and increasing global demand...

Evaluate-Wins-Best-Decision-Management-Solution-2023-AI-Breakthrough-Awards-featured-image

Evaluate Wins Best Decision Management Solution at 2023 AI Breakthrough Awards

LONDON AND BOSTON – June 21, 2023 – Evaluate, a Norstella company, today announced that its Evaluate...

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

London, UK and Boston, MA, Nov. 1, 2022 – Norstella, a global leader with end-to-end solutions that smooth...

Matthew-Wright-Chief-Financial-Officer-featured-image

Evaluate Appoints Matthew Wright as Chief Financial Officer

London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive...

Four-Prominent-Pharmaceutical-Solutions-Providers-Launch-Norstella-featured-image

Four Prominent Pharmaceutical Solutions Providers Launch Norstella to Drive Innovation and Get Patients Access to Life-Saving Therapies Faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate,...

Evaluate Report Signals Orphan Drug Market Is Niche No More

London, UK – 28 April 2022 – Evaluate, the leading provider of market intelligence and predictive analytics...

evaluate-Strategic-Collaboration-Treehill-Partners-featured-image

Evaluate Announces Global Strategic Collaboration with Treehill Partners

London, UK and New York, USA –21 April 2022 – Evaluate and Treehill Partners today announced that they...

Press Enquiries

We work with healthcare and business reporters globally. Learn how Evaluate’s data and expert insights enhance your story.

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate.

Your information will be used in accordance with our Privacy notice.